子痫前期:无症状性心力衰竭的重要危险因素
这项横断面队列研究纳入107名既往子痫前期女性和41名既往妊娠平顺的对照女性,于产后4-10年进行心血管风险评估,包括心脏超声、血压测量和代谢综合征决定因素评估。子痫前期组无症状性心力衰竭B期(HF-B)患病率约为对照组的3.5倍(25% vs 7%,P<0.01);校正产后间隔、高血压和高密度脂蛋白后,子痫前期与HF-B显著相关(校正比值比4.4,95%CI 1.0-19.1)。在既往子痫前期组中,高血压前期与HF-B显著相关(比值比4.3,95%CI 1.4-12.7),而代谢综合征决定因素则无显著关联。
要点
- 子痫前期组产后4-10年无症状性HF-B患病率为25%,对照组为7%(P<0.01)。
- 校正混杂因素后,子痫前期与HF-B显著相关(校正比值比4.4,95%CI 1.0-19.1)。
- 既往子痫前期组中高血压前期与HF-B显著相关(比值比4.3,95%CI 1.4-12.7)。
核心结论
- 子痫前期与女性无症状性心脏异常风险增加约四倍相关。
- 高血压前期显然显著增加该风险,而代谢综合征决定因素则无显著关联。
研究设计与样本
- 横断面队列研究,纳入107名既往子痫前期女性和41名既往妊娠平顺的对照女性。
- 于产后4-10年进行心血管风险评估,包括心脏超声、血压测量和代谢综合征决定因素评估。
- 根据美国心脏协会指南将无症状结构和功能性心脏异常分类为HF-B。
- 高血压前期定义为收缩压120-139 mmHg和/或舒张压80-89 mmHg。
- 采用单因素和多因素回归分析计算子痫前期及传统危险因素与HF-B的关联。
主要发现
- 子痫前期组无症状性HF-B患病率约为对照组的3.5倍(25% vs 7%,P<0.01)。
- 子痫前期组中67%存在向心性重构,22%存在射血分数轻度受损。
- 校正产后间隔、高血压和高密度脂蛋白后,子痫前期与HF-B显著相关(校正比值比4.4,95%CI 1.0-19.1)。
- 在既往子痫前期组中,高血压前期与HF-B显著相关(比值比4.3,95%CI 1.4-12.7),而代谢综合征决定因素则无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Pre-eclampsia (PE) is associated with both postpartum structural asymptomatic heart disease (i.e. heart failure Stage B (HF-B)) and conventional cardiovascular (CV) risk factors. We aimed to evaluate the extent to which PE, adjusted for conventional CV risk factors, is associated independently with asymptomatic cardiac abnormalities postpartum. METHODS: In this cross-sectional cohort study, 107 formerly pre-eclamptic women and 41 women with uneventful previous pregnancy (controls) were invited for CV risk assessment 4-10 years postpartum. This included cardiac ultrasound, blood pressure (BP) measurement and evaluation of metabolic syndrome determinants. Asymptomatic structural and functional cardiac abnormalities were classified as HF-B, according to the American Heart Association guidelines. Prehypertension was defined as systolic BP of 120-139 mmHg and/or diastolic BP of 80-89 mmHg. Univariate and multivariate regression analyses were performed to calculate associations of PE and conventional risk factors with HF-B. RESULTS: The prevalence of asymptomatic HF-B was approximately 3.5-fold higher in the PE group compared with controls (25% vs 7%, P < 0.01); 67% of this group had concentric remodeling and 22% had mildly impaired ejection fraction. After adjustment for postpartum interval, hypertension and high-density lipoprotein, PE was significantly associated with HF-B (adjusted odds ratio, 4.4 (95% CI, 1.0-19.1)). Moreover, in the formerly pre-eclamptic group, prehypertension was associated significantly with HF-B (odds ratio, 4.3 (95% CI, 1.4-12.7)), while metabolic syndrome determinants were not. CONCLUSION: PE is associated with a four-fold increased female-specific risk of asymptomatic cardiac abnormalities. Prehypertension apparently increases this risk significantly, while metabolic syndrome determinants do not. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Ghossein-Doha C, van Neer J, Wissink B, et al. Pre-eclampsia: an important risk factor for asymptomatic heart failure. Ultrasound Obstet Gynecol. 2017. PMID: 27804179. doi:10.1002/uog.17343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。